Podcast: This Week in Managed Care—Limiting Surprising Medical Bills and Other Health News

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

A quick roundup episode of major health policy developments, from shifting COVID-19 vaccine guidance and scientific publishing controversies to rising cancer care costs and the impact of oncology biosimilars.

TP53 aberrations and circulating tumor DNA burden were found to be predictors of poor outcomes in high-risk patients with large B-cell lymphoma.

Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.

The Congressional Budget Office estimates the package would add $2.4 trillion to the national deficit over a decade and leave 10.9 million more Americans without health insurance.

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.